New Medicines and Generic Versions Bringing a new medicine to market is an extremely long, expensive, and involved process.[9] Once a drug has completed all the requisite trials and been approved for use, the innovator must present a monograph, or chemical profile, of the drug???s contents to establish safe variation limits from the stated contents.